WASHINGTON - The U.S. Food and Drug Administration has granted emergency use authorization for another COVID-19 at-home test.The agency approved the Quidel QuickVue At-Home COVID-19 Test, allowing eligible consumers to rapidly test themselves for the coronavirus without having to send a sample to a laboratory for analysis.Only health care providers can prescribe the nasal swab test for patients who suspect they may have the coronavirus within the first six days of experiencing symptoms.
Results can be delivered in as little as 10 minutes."The FDA continues to prioritize the availability of more at-home testing options in response to the pandemic," Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a news.